Showing results (131-140 of 625) with videos related to
Sort By:
Pageof 63
Integrated Blood Pressure Control|March 30, 2012
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomilMassimo Volpe, Carmine SavoiaAging Clinical and Experimental Research|April 28, 2006
Integrated cardiovascular risk management for the future: lessons learned from the ASCOT trialMassimo Volpe, Giuliano TocciExpert Review of Cardiovascular Therapy|August 4, 2011
Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapyGiuliano Tocci, Massimo VolpeHigh Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 27, 2011
2010 position paper of the Italian Society of Hypertension (SIIA): angiotensin receptor blockers and risk of cancerMassimo Volpe, Alberto Morganti, High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 8, 2011
Modern clinical management of arterial hypertension: fixed or free combination therapies?Giuliano Tocci, Massimo VolpeVascular Health and Risk Management|April 15, 2011
Olmesartan medoxomil for the treatment of hypertension in children and adolescentsGiuliano Tocci, Massimo VolpeAmerican Journal of Hypertension|June 17, 2011
Redefining blood pressure targets in high-risk patients?: lessons from coronary endpoints in recent randomized clinical trialsMassimo Volpe, Giuliano TocciCardiology|May 3, 2013
Plasma renin and cardiovascular risk: what is the evidence for an association?Massimo Volpe, Thomas UngerDrugs & Aging|October 31, 2013
Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidenceMassimo Volpe, Giuliano TocciCardiovascular Therapeutics|October 26, 2018
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartanStefano Omboni, Massimo VolpePageof 63